Medical device licence · 85070 · Class 2
LIPOPROTEIN (A) TEST KITS
No longer licensed: discontinued at renewal
Licence status Discontinued at renewal; first licensed February 3, 2011; ended October 31, 2014. It is in Health Canada’s archive of licences no longer in force.
- Licence number
- 85070
- Licence holder
- Roche Diagnostics GmbhMannheim, Germany
- Risk class
- Class II (low to moderate risk)
- Licence type
- Test Kit
- First licensed
- February 3, 2011
- Ended
- October 31, 2014
- Devices covered
- 3
Devices on this licence
By name, as listed. The official record lists model numbers and identifiers.
- LIPOPROTEIN (A) (TINA-QUANT LIPOPROTEIN (A) FOR ROCHE/HITACHI AND MODULAR P ANALYZERS)
- LPALX (TINA-QUANT LIPOPROTEIN (A) (LATEX) FOR CABAS C 311 AND COBAS C 501/502)
- LPALX (TINA-QUANT LIPOPROTEIN (A) (LATEX) FOR COBRAS C 701 SYSTEM)
Class I devices, the lowest-risk group, mostly need no device licence, so most are not in this list.